Torre F - Search Results

1

Induction of T-helper cell response to hepatitis B core antigen in chronic hepatitis B: a major factor in activation of the host immune response to the hepatitis B virus.

Marinos G, Torre F, Chokshi S, Hussain M, Clarke BE, Rowlands DJ, Eddleston AL, Naoumov NV, Williams R. Marinos G, et al. Among authors: torre f. Hepatology. 1995 Oct;22(4 Pt 1):1040-9. doi: 10.1016/0270-9139(95)90607-x. Hepatology. 1995. PMID: 7557849

2

Tumor necrosis factor receptors in patients with chronic hepatitis B virus infection.

Marinos G, Naoumov NV, Rossol S, Torre F, Wong PY, Gallati H, Portmann B, Williams R. Marinos G, et al. Among authors: torre f. Gastroenterology. 1995 May;108(5):1453-63. doi: 10.1016/0016-5085(95)90694-0. Gastroenterology. 1995. PMID: 7729638

3

Hepatitis B virus variants with core gene deletions in the evolution of chronic hepatitis B infection.

Marinos G, Torre F, Günther S, Thomas MG, Will H, Williams R, Naoumov NV. Marinos G, et al. Among authors: torre f. Gastroenterology. 1996 Jul;111(1):183-92. doi: 10.1053/gast.1996.v111.pm8698197. Gastroenterology. 1996. PMID: 8698197

4

Clinical implications of mutations in the hepatitis B virus genome.

Torre F, Naoumov NV. Torre F, et al. Eur J Clin Invest. 1998 Aug;28(8):604-14. doi: 10.1046/j.1365-2362.1998.00346.x. Eur J Clin Invest. 1998. PMID: 9767354 Review. No abstract available.

5

Direct evidence that naturally occurring mutations within hepatitis B core epitope alter CD4+ T-cell reactivity.

Torre F, Cramp M, Owsianka A, Dornan E, Marsden H, Carman W, Williams R, Naoumov NV. Torre F, et al. J Med Virol. 2004 Mar;72(3):370-6. doi: 10.1002/jmv.20016. J Med Virol. 2004. PMID: 14748060

6

Evolution of wild-type and precore mutant HBV infection after liver transplantation.

Torre F, Wong PY, Macartney M, Williams R, Naoumov NV. Torre F, et al. J Med Virol. 1999 Sep;59(1):5-13. J Med Virol. 1999. PMID: 10440801

7

Novel immunoassay for the detection of hepatitis B surface 'escape' mutants and its application in liver transplant recipients.

Ijaz S, Torre F, Tedder RS, Williams R, Naoumov NV. Ijaz S, et al. Among authors: torre f. J Med Virol. 2001 Mar;63(3):210-6. doi: 10.1002/1096-9071(200103)63:3<210::aid-jmv1002>3.0.co;2-c. J Med Virol. 2001. PMID: 11170059 Clinical Trial.

8

Elevations in alanine aminotransferase levels late in the course of antiviral therapy in hepatitis C virus RNA-negative patients are associated with virological relapse.

Basso M, Giannini EG, Torre F, Blanchi S, Savarino V, Picciotto A. Basso M, et al. Among authors: torre f. Hepatology. 2009 May;49(5):1442-8. doi: 10.1002/hep.22810. Hepatology. 2009. PMID: 19350657

9

Interferon retreatment in chronic hepatitis C: which patients to choose, and what schedule to use.

Picciotto A, Campo N, Brizzolara R, Sinelli N, Torre F, Cipriani AG, Ponassi I, Varagona G, Grasso A, De Leo P, De Conca V, Mesiti S, Marenco G, Menardo G, Dodero M, Celle G. Picciotto A, et al. Among authors: torre f. Eur J Gastroenterol Hepatol. 1999 Jun;11(6):649-53. Eur J Gastroenterol Hepatol. 1999. PMID: 10418937

10

Soluble beta2-mu-associated and beta2-mu-free HLA class I heavy chain serum levels in interferon-alpha nonresponder chronic hepatitis C patients. Markers of immune activation, and response to antiviral retreatment.

Puppo F, Torre F, Contini P, Ghio M, Brenci S, Brizzolara R, Sinelli N, Campo N, Indiveri F, Picciotto A. Puppo F, et al. Among authors: torre f. J Clin Immunol. 2000 Nov;20(6):486-90. doi: 10.1023/a:1026468001834. J Clin Immunol. 2000. PMID: 11202239 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

704 results

Search Page

Filters